Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M169,732Revenue $M44,033Net Margin (%)10.0Z-Score3.0
Enterprise Value $M179,956EPS $1.5Operating Margin %14.4F-Score4
P/E(ttm))38.6Cash Flow Per Share $6.3Pre-tax Margin (%)12.6Higher ROA y-yN
Price/Book3.410-y EBITDA Growth Rate %3.1Quick Ratio1.6Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %-6.3Current Ratio1.8Lower Leverage y-yN
Price/Cash Flow7.1y-y EBITDA Growth Rate %-6.6ROA % (ttm)4.2Higher Current Ratio y-yN
Dividend Yield %3.0Insider Buy (3m)0ROE % (ttm)8.9Less Shares Outstanding y-yY
Payout Ratio %79.0Shares Outstanding M2,922ROI % (ttm)6.0Gross Margin Increase y-yN

Gurus Latest Trades with MRK

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MRKVanguard Health Care Fund 2014-06-30 Reduce-0.28%$54.83 - $59.62
($57.16)
$ 58.132%Reduce -4.85%33,889,948
MRKJean-Marie Eveillard 2014-03-31 Add0.34%$49.49 - $57.47
($54.09)
$ 58.138%Add 15820.6%2,236,839
MRKDavid Dreman 2014-03-31 Buy 0.02%$49.49 - $57.47
($54.09)
$ 58.138%New holding, 4431 sh.4,431
MRKJoel Greenblatt 2014-03-31 Buy $49.49 - $57.47
($54.09)
$ 58.138%New holding, 3567 sh.3,567
MRKJames Barrow 2014-03-31 Reduce-0.48%$49.49 - $57.47
($54.09)
$ 58.138%Reduce -22.72%22,739,030
MRKDodge & Cox 2014-03-31 Reduce-0.45%$49.49 - $57.47
($54.09)
$ 58.138%Reduce -18.11%39,959,196
MRKVanguard Health Care Fund 2014-03-31 Reduce-0.15%$49.49 - $57.47
($54)
$ 58.138%Reduce -2.58%35,616,848
MRKGeorge Soros 2014-03-31 Sold Out -0.06%$49.49 - $57.47
($54.09)
$ 58.138%Sold Out0
MRKJohn Hussman 2014-03-31 Sold Out -0.01%$49.49 - $57.47
($54)
$ 58.138%Sold Out0
MRKGeorge Soros 2013-12-31 Buy 0.06%$45.09 - $50.18
($47.86)
$ 58.1322%New holding, 150000 sh.150,000
MRKRuane Cunniff 2013-12-31 Buy $45.09 - $50.18
($47.86)
$ 58.1322%New holding, 4075 sh.4,075
MRKJean-Marie Eveillard 2013-12-31 Reduce-0.16%$45.09 - $50.18
($47.86)
$ 58.1322%Reduce -98.76%14,050
MRKLeon Cooperman 2013-12-31 Sold Out -0.15%$45.09 - $50.18
($47.86)
$ 58.1322%Sold Out0
MRKCharles Brandes 2013-12-31 Reduce-0.14%$45.09 - $50.18
($47.86)
$ 58.1322%Reduce -8.39%2,476,201
MRKJean-Marie Eveillard 2013-09-30 Reduce-0.16%$46.55 - $48.58
($47.88)
$ 58.1321%Reduce -49.6%1,134,041
MRKGeorge Soros 2013-09-30 Sold Out -0.13%$46.55 - $48.58
($47.88)
$ 58.1321%Sold Out0
MRKJoel Greenblatt 2013-09-30 Sold Out -0.05%$46.55 - $48.58
($47.88)
$ 58.1321%Sold Out0
MRKJames Barrow 2013-06-30 Add1.32%$44.35 - $49.44
($46.81)
$ 58.1324%Add 134.86%29,318,754
MRKCharles Brandes 2013-06-30 Add0.48%$44.35 - $49.44
($46.81)
$ 58.1324%Add 43.39%2,703,540
MRKGeorge Soros 2013-06-30 Buy 0.13%$44.35 - $49.44
($46.81)
$ 58.1324%New holding, 250000 sh.250,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MRK is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
MRK Vanguard Health Care Fund 2014-06-3033,889,9481.165.2-4.85%
MRK Jean-Marie Eveillard 2014-03-312,236,8390.080.34+15820.6%
MRK Joel Greenblatt 2014-03-313,56700New Buy
MRK David Dreman 2014-03-314,43100.02New Buy
MRK Ruane Cunniff 2014-03-314,40900+8.2%
MRK Prem Watsa 2014-03-3112,00000.05
MRK Charles Brandes 2014-03-312,451,1250.081.8-1.01%
MRK Mario Gabelli 2014-03-31160,3160.010.05-18.07%
MRK Dodge & Cox 2014-03-3139,959,1961.372.3-18.11%
MRK James Barrow 2014-03-3122,739,0300.781.8-22.72%
MRK George Soros 2014-03-31000Sold Out
MRK John Hussman 2014-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


MRK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
FRAZIER KENNETH CChairman, President & CEO 2014-07-10Sell9,987$58.030.17view
GRADDICK WEIR MIRIAN MExe V-P, HR 2014-07-07Sell180,047$59.16-1.74view
GRADDICK WEIR MIRIAN MExe V-P, HR 2014-07-07Sell180,047$59.16-1.74view
Deese Willie AExe V-P & Pres. MMD 2014-06-27Sell72,290$58.26-0.22view
FRAZIER KENNETH CChairman, President & CEO 2014-06-10Sell9,985$58.060.12view
Schechter Adam HEVP & Pres-Global Human Health 2014-05-14Sell10,527$55.913.97view
FRAZIER KENNETH CChairman, President & CEO 2014-05-09Sell10,220$555.69view
FRAZIER KENNETH CChairman, President & CEO 2014-04-10Sell10,047$57.241.55view
Kuhlik Bruce NExe V-P & Gen Counsel 2014-04-04Sell145,225$56.433.01view
Golestani ClarkEVP & Chief Info Officer 2014-02-14Sell5,990$55.474.8view

Press Releases about MRK :

Quarterly/Annual Reports about MRK:

    News about MRK:

    Articles On GuruFocus.com
    UnitedHealth Group Up on Weak Day for the Dow Jul 17 2014 
    U.S. Markets Regain Losses from Last Week Jul 14 2014 
    Abner Herrman Is Increasing Position in the Pharmaceutical Sector Jul 11 2014 
    U.S. Equity Markets Continue to Hit New Highs Jun 15 2014 
    Auxier Asset Management's Auxier Report - First Quarter 2014 May 06 2014 
    Will Pfizer’s Q1 2014 Earnings Beat the Street on May 5, 2014? May 05 2014 
    Wrong Marketing Lesson by Big Pharma May 03 2014 
    Vanguard Health Care Fund's Top Quarterly Holdings Apr 30 2014 
    Bill Nygren Comments on Merck Apr 10 2014 
    Abbvie Inc. (ABBV) Dividend Stock Analysis Mar 21 2014 


    More From Other Websites
    Stocks mixed; Fed tapers and GDP better than forecast Jul 30 2014
    Second Quarter Results Show Earnings And Revenue Growth Jul 30 2014
    Hospira Beats on Earnings and Sales in Q2, Boosts Guidance Jul 30 2014
    Stocks close lower as global tensions take a toll Jul 29 2014
    Merck, Pfizer Ramping R&D After Q2 Earnings Beat Jul 29 2014
    US STOCKS-Wall Street ends down; Twitter rallies after-hours Jul 29 2014
    Path for Skirting U.S. Taxes Widens With REIT Blueprint Jul 29 2014
    Pharmaceutical ETFs Are Health Care Sector Standouts Jul 29 2014
    US STOCKS-Wall St edges lower on UPS outlook, telecom shares rally Jul 29 2014
    US STOCKS-Wall St edges lower on UPS outlook, telecom shares rally Jul 29 2014
    Stocks inch up ahead of economic data Jul 29 2014
    Stocks inch up ahead of economic data Jul 29 2014
    [video] Pfizer and Merck Top Quarterly Earnings Expectations, Shares Rise Jul 29 2014
    Treasury prices steady after 5-year notes auction Jul 29 2014
    Merck Pops On Good Profits, Tax Deal? Jul 29 2014
    Stocks turn mixed ahead of economic data Jul 29 2014
    Stocks turn mixed ahead of economic data Jul 29 2014
    Merck (MRK) On Momo Momentum Watch Today Jul 29 2014
    US STOCKS-Wall St flat as telecom gains offset by earnings Jul 29 2014
    US STOCKS-Wall St flat as telecom gains offset by earnings Jul 29 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide